Investments
Details of our portfolio will appear as our investments are completed.
27 July 2007 - Acrobot
The London Technology Fund (LTF), London’s specialist investor in new technology companies, today announced it has completed an investment in Acrobot, a company focusing on computer assistance for orthopaedic surgery. LTF is part of a syndicate investing up to £2.6m. The syndicate includes PUK Ventures and Imperial Innovations Group plc and was co-led by LTF and PUK Ventures. Following the investment an experienced finance director will be appointed and the company will move to new premises.
For more information, please see latest news, our press release and www.acrobot.co.uk.
16 July 2007 - Immune Targeting Systems
The London Technology Fund (LTF), London’s specialist investor in new technology companies, today announced it has completed an investment in Immune Targeting Systems (ITS) Limited, a company which is developing vaccines for mutating viruses. This is ITS’s first significant round of funding and LTF is the only UK investor in an international syndicate which is investing up to £3.5m. The syndicate includes Novartis Venture Fund (Switzerland), HealthCap (Sweden) and Truffle Capital (France). The London Development Agency will also be contributing an Exceptional Development Project award of £500,000 under the Grant for Research and Development scheme. As a result of the investment the company has been able to recruit its core team of development scientists and will move into dedicated facilities at the London BioScience Innovation Centre. In September 2007 the funding round was increased to £4m.
For more information, please see latest news, our press release and www.its-innovation.co.uk.
17 January 2007 - ApplianSys
ApplianSys, which designs and builds server appliances, has attracted funding of £620,000. London Technology Fund (LTF), London's specialist investor in new technology companies, invested as part of a syndicate which included The Capital Fund and business angels. Following the investment an experienced finance director will be appointed. A second close on 28 February 2007 took the total amount raised by ApplianSys to £720,000.
For more information, please see latest news, our press release and www.appliansys.com.
30 November 2006 - Intellistream
Intellistream, the developer of a new turnkey solution for 3G video content aggregators, has attracted funding of £355,000. London Technology Fund (LTF), London's specialist investor in new technology companies, led the round, which also included investment from management and business angels. Following the investment an experienced software executive will become Chief Executive and a new finance director will join the board. In April 2008 LTF announced the first close of an up to £1m further round for Intellistream. The funding round follows the first significant contract for Intellistream’s technology and was led by LTF. The funding will enable Intellistream to address further its initial target market, providing the ability remotely to access and control security/CCTV cameras on the move. Intellistream’s platform offers advantages over competing interactive mobile video solutions through being easy to manage, readily scalable, providing high levels of reliability and low latency/high responsiveness.
For more information, please see latest news and www.intellistream.co.uk.
20 September 2006 - Dynamic IT Management Services
Dynamic IT Management Services, a supplier of specialist software for the foreign exchange market, has attracted funding of £900,000. London Technology Fund (LTF) led the round, which also included investment from management and business angels. Following the investment John Jessop will become Executive Chairman and a new finance director will join the board. The London Technology Fund has subsequently announced a partial exit.
For more information, please see latest news and our press release.
28 March 2006 - deltaDOT
London Technology Fund's first investment is part of an important funding round for Imperial College spin-out, deltaDOT. deltaDOT is a developer of biotools to enhance productivity in pharmaceutical and biotechnology research.
For more information, please see latest news, our press release and www.deltadot.com.
Please be sure to read this important legal information.